⏰REMEDi4ALL Academic Bootcamp deadline extended - limited places still remain!⏰ Join the REMEDi4ALL Academic Bootcamp (11–12 Mar 2026, Cambridge, UK) for hands-on drug repurposing training. Fully funded for selected participants. 📅 Apply now ➡️ https://loom.ly/4QEaVoc

🚨 Today is the deadline to submit your abstract for the #iDR26 Poster Session! Showcase your work, stories, and experiences to an international audience of professionals and thought leaders in the drug repurposing field! 👉 Learn more and submit your abstract here: https://loom.ly/XvNoRTM

Bursaries available for patients and patient representatives at #iDR26! In order to facilitate meaningful patient participation at iDR26, participants may be granted financial support to cover travel, accommodation, and ticketing. 👉 Learn more about patient bursaries here: https://loom.ly/Ff53lz0

💊 Could an existing medicine offer new options for people living with Osteogenesis Imperfecta, and could you take part? The REMEDi4ALL MOI-A study is recruiting patients across Europe to explore whether repurposing losartan could benefit people living with OI. 📽️ More: https://loom.ly/HT__zsw

⏰ REMEDi4ALL Academic Bootcamp: applications close tomorrow! This is your last chance to apply for the REMEDi4ALL Academic Bootcamp (11–12 March 2026, Cambridge, UK) and take your drug repurposing idea to the next stage with expert support. 🗓️Deadline: 14 January 🔗Apply: https://loom.ly/4QEaVoc

⏳ 1 week to go until applications close! Don’t miss your chance to join the REMEDi4ALL Academic Bootcamp (11–12 March 2026, Cambridge, UK) and take your drug repurposing idea to the next stage with expert support. 🗓️ Applications close 14 Jan 🔗 Register now: https://loom.ly/4QEaVoc

🧭 Join the global drug repurposing community at #iDR26 and contribute your work or perspective. You can take part by submitting an abstract for the Poster Session or by applying for a Lightning Talk. Read more and find the deadlines below! ➡️ Apply here: https://loom.ly/XvNoRTM

💊Interested in taking your drug repurposing idea to the next level? 🔬 Join the REMEDi4ALL Academic Bootcamp on 11–12 March 2026 in Cambridge, UK: a hands-on programme to help researchers advance promising repurposing concepts. ⌛ Apply by 14 Jan: https://loom.ly/4QEaVoc

📚New from REMEDi4ALL demonstrator project: Can an existing blood pressure medicine improve bone health in osteogenesis imperfecta? A phase II trial is repurposing losartan to target overactive TGFβ signalling in adolescents & adults with OI. 🔗 https://loom.ly/Eb_ueT0 #DrugRepurposing

❄️ Season’s greetings from #REMEDi4ALL! We are grateful for your support in advancing drug repurposing and look forward to continued impact in the year ahead.

Bursaries are available for patients and patient representatives to attend iDR26! Meaningful patient participation is a core element of iDR26. Below, patients and patient organisations share their experiences of attending last year’s conference. 👉 More information here: https://loom.ly/Ff53lz0

🚨Breaking! #iDR26 is excited to announce our four conference tracks for this year🚨 🌐Rare Diseases 🔍Discovery 💼Industry 👥Community Interested in learning more about these key areas in drug repurposing? Join us on 12-13 May in Brussels (limited early bird tickets)➡️ https://loom.ly/9dw7qdk

Prof. Irena Mlinarič Raščan of the University of Ljubljana, a REMEDi4ALL partner, was recently featured in DELO, Slovenia’s largest daily newspaper, in an in-depth article exploring the future of drug repurposing and her work with #REMEDi4ALL. 🔗 Read the article here: https://loom.ly/9kv7-MY

🔍New open-access REMEDi4ALL resource for in silico drug repurposing! Two annotation workflows (KNIME + Python/Neo4j) help extract, harmonise & explore chemical and bioactivity data across >5000 compounds for drug repurposing! 🔗Read the open access article in Database➡️ https://loom.ly/nboSzbk

📚 A new study from REMEDi4ALL partner University of Ljubljana introduces a human cell–based laboratory model to improve understanding of cytokine storm: overreaction of the immune system in severe infections. Read the full article here➡️ https://loom.ly/nYdimM0

Get involved in the global drug repurposing community at #iDR26 and don’t miss your chance to contribute! Hear from last year's participants below! 🔬 Poster Session – Deadline: 10 January 2026 ⚡ Lightning Talks - Deadline: 27 February 2026 Submit your application here: https://loom.ly/XvNoRTM#iDR26

🎓 Applications are open for the REMEDi4ALL Drug Repurposing Bootcamp! A hands-on programme with expert guidance to help researchers take repurposing ideas toward real patient impact. Funding is provided for selected participants. 📝 Apply by 14 Jan here: https://loom.ly/4QEaVoc

📣 New Medicines Reimagined story! Nitisinone went from an herbicide to an approved treatment for two rare diseases (HT-1 & AKU). A remarkable example of #DrugRepurposing powered by science and patient advocacy. ➡️ https://loom.ly/4Qp4-yg

Help shape the future of drug repurposing at #iDR26 🧭 Join a diverse community of stakeholders, collaborating to strengthen the drug repurposing ecosystem and navigate the future of cutting-edge science to maximise patient benefit. 🔗 More details: https://loom.ly/ToR-dtw

Last week, REMEDi4ALL spoke to the TAR Network, joining 27 participants to discuss how resources can support repurposing initiatives. ☑️Highlights: concierge support, funding marketplace, value assessment tool, webinars, and policy/patient engagement. 👥More collaboration ahead!

🎓Join us for the REMEDi4ALL Academic Bootcamp 2026! Following a highly successful inaugural edition, applications are now open for the 2026 REMEDi4ALL Academic Bootcamp at Wellcome Genome Campus (Cambridge, UK)! 🗓️Dates: 11–12 March 2026 ➡️Apply here by 14 Jan: https://loom.ly/4QEaVoc

🗞️Breaking news: REMEDi4ALL is supporting an important effort to advance treatment options for children with KCNQ2-Developmental and Epileptic Encephalopathy, a rare early-onset epilepsy with limited treatment options. More➡️ https://loom.ly/J3ocQH4

🟣 Over the next few days, REMEDi4ALL partner Medicines for Europe will highlight how value added medicines (VAMs) are transforming access by rethinking, reinventing and optimising existing medicines. Follow #VAMWeek 2025 to find out more!

If you’re a patient or part of a patient group, #iDR26 offers a chance to: 🔹 Share your experiences and perspectives in discussions shaping the future of drug repurposing 🔹 Hear directly from researchers, clinicians and regulators Register for iDR26 here: https://loom.ly/Qo4ko8s

🎬 Inside the 2025 REMEDi4ALL Hackathon! Early career researchers from across Europe gathered near Montserrat to tackle real-world challenges in drug repurposing for rare neurodevelopmental disorders. Catch the highlights ➡️https://loom.ly/N6tXCHs

Share your experience and ideas with the global drug repurposing community at #iDR26! Submit your abstract for the 🔬 Poster Session or apply for a ⚡ Lightning Talk here: https://loom.ly/XvNoRTM 👉 Discover our bursaries for patients & patient groups: https://loom.ly/Ff53lz0#iDR26

💻💡Last week REMEDi4ALL welcomed around 80 participants to our webinar on IP Strategies for Repurposing! Highlights included discussion on why IP strategy matters, patent basics & business strategies. 🎬Register via the REMEDi4ALL Digital Academy for the recording: https://loom.ly/IeBJ9No

Next week: REMEDi4ALL and the Funders Network present to the TAR Network. 📅 27 Nov 2025 | 12:00–13:00 CET Alicia Soler, Heleen van der Meer and Pan Pantziarka will introduce REMEDi4ALL to 30+ charity funders, exploring how to advance drug repurposing together. Register: https://loom.ly/ZkaHBcA

💜 #WorldPancreaticCancerDay highlights the urgent need for faster, more effective therapeutic options. REMEDi4ALL recently co-organised a Multistakeholder Meeting with EURORDIS to explore how #DrugRepurposing can address these needs. 👉 Meeting summary: https://loom.ly/3u2fS7g

🌍 Are you looking to connect with a global community shaping the future of drug repurposing? If so, iDR26 is the event for you! Join us 12&13 May in Brussels to explore how repurposing can help deliver treatments for patients worldwide. 🎟️ Learn more: https://loom.ly/ToR-dtw

💻📣 This week! Last chance to join the REMEDi4ALL webinar “IP Strategies for Repurposing” on Fri 21 Nov | 14:00–15:30 CET. Discover how IP strategies accelerate drug repurposing projects with LifeArc, King’s College London & Beacon for Rare Diseases. 🔗 https://loom.ly/bG6rhso

🔍 REMEDi4ALL at ISPOR Europe 2025 Partners from Syreon Research Institute represented REMEDi4ALL at #ISPOREurope2025 in Glasgow — sharing insights on policy barriers to drug repurposing and patient engagement in early HTA for Losartan in Osteogenesis Imperfecta. #DrugRepurposing #HTA

Why join #iDR26? Join a global community driving the future of drug repurposing. 💡 Cutting-edge science 🤝 Collaboration ⚖️ Policy & access 🔬 Real-world case studies Connect, share, and shape faster, more affordable treatments. 🔗 https://remedi4all.org/iDR26

📚REMEDi4ALL publishes a new systematic review in the British Journal of Pharmacology, identifying 33 key policy barriers limiting drug repurposing across Europe. Findings will guide future reforms to improve access to repurposed medicines. 📘More here: https://loom.ly/zCuz-oY

🏠First REMEDi4ALL Marketplace Meeting! The first REMEDi4ALL Marketplace meeting brought together 30+ participants, including 15 funding organisations. The Marketplace connects funders and project developers to boost impactful collaborations in drug repurposing. 🔗 https://loom.ly/YBi0wZU

📣 Medicines Reimagined Stories begins! Each month, we show how existing medicines find new life through #DrugRepurposing — turning known molecules into new treatments. 1st story: Sotatercept (Winrevair) — from anaemia to pulmonary hypertension (PAH). ➡️ Download here: https://loom.ly/4Qp4-yg

📣 Join us on 21 Nov for the REMEDi4ALL webinar on IP Strategies for Repurposing! With Beacon for Rare Diseases, LifeArc & King’s College London, discover how robust IP planning can accelerate your drug repurposing project. 🔗 https://loom.ly/bG6rhso

🎬 #iDR25 highlight reel is here! Relive the best moments from Amsterdam, where 300+ participants & 60+ experts came together to explore how AI, innovative trials & collaboration can transform #DrugRepurposing. ➡️ Watch the recap on the Conference hub: https://remedi4all.org/idr25-conference/

📅 It’s official! #iDR26 lands in Brussels on 12–13 May 2026. Join the leading international conference on drug repurposing to explore the next chapter in patient-centred innovation from rare diseases and AI to policy and funding. Early Bird tickets available now ➡️ https://remedi4all.org/iDR26

💻IP Strategies for Repurposing webinar 🗓️ 21 Nov | 14:00–15:30 CET Navigating the complex IP landscape in #DrugRepurposing? Join REMEDi4ALL with: ➡️ Madhu Madhusudhan & Svetlana Gracheva (LifeArc) ➡️ John Liddicoat (King’s College London) ➡️ Beacon for Rare Diseases 🔗: https://loom.ly/bG6rhso

🎤 #REMEDi4ALL takes the stage at the #iRDiRC General Assembly Meeting in Paris! Gathier Bouche from The Anticancer Fund joined a session on EU drug repurposing initiatives, where he showcased how REMEDi4ALL is advancing the repurposing of medicines. 🔗 https://irdirc.org/

💻New REMEDi4ALL Funders Network Webinar Barbara Goodman (Cures Within Reach) & Hans Platteeuw (Galenicap) shared seven #DrugRepurposing projects that reached patients plus key lessons learned. The Funders Network unites funders to boost collaboration & impact. 🔗More: https://loom.ly/ZTiu4mQ

At the 2025 #REMEDi4ALL Hackathon near Montserrat, 14 early career researchers from 10 countries joined experts to tackle real-world #DrugRepurposing challenges in rare neurodevelopmental disorders. Read the full event summary and discover who won here➡️https://loom.ly/N6tXCHs

👥 REMEDi4ALL #Hackathon2025: insights from our participants! As the Hackathon wraps up, participants share how speaking with patients shaped their approach to drug repurposing, showing how patient perspectives drive real-world impact. 🏆 Stay tuned - winner announced soon! 🔗 www.remedi4all.org

💻 Day 2 at the REMEDi4ALL Hackathon – the scientific programme! Participants are exploring and prioritising drug repurposing candidates for neurodevelopmental disorders, turning data into decisions and shaping target product profiles. Next: integrating patient perspectives for real-world impact!

💊Kicking off the REMEDi4ALL #Hackathon! 14 early-career researchers have joined us in Barcelona to explore repurposing candidates for three neurodevelopmental disorders. 📹 Stay tuned to hear directly from our participants and organisers as the week unfolds!

💻 Upcoming webinar: IP Strategies for Repurposing 🗓️ Fri 21 Nov | 14:00-15:30 CET Join REMEDi4ALL with Beacon for Rare Diseases, LifeArc & King’s College London to explore IP challenges, strategies & practical tips for drug repurposing. 🔗 Register here: https://loom.ly/bG6rhso

📄New publication from REMEDi4ALL. Researchers at FIMM have published in iScience on detecting spatial artefacts (systematic errors) in drug screening: key for advancing new and repurposed medicines. 🔗Our interview: https://loom.ly/UV5SWig 🔗Full publication: https://loom.ly/UV5SWig

👥 REMEDi4ALL joined our sister project REPO4EU at #RExPO25 in Barcelona for a programme on innovation in drug repurposing & systems medicine. Read highlights from our session: patient engagement, training, new tools & collaboration 👉 https://loom.ly/k4uER7w

🔬 New REMEDi4ALL dataset! Phospholipidosis, the abnormal build-up of lipids in cells, can distort drug screening results and slow development. REMEDi4ALL has shared imaging data to improve understanding of this phenomenon and support drug repurposing research. 🔗 https://loom.ly/sKA5Hp4